Novozymes A/S
F:NZM2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novozymes A/S
F:NZM2
|
DK |
|
T
|
TAG Immobilien AG
XMUN:TEG
|
DE |
|
DBV Technologies SA
PAR:DBV
|
FR |
|
A
|
Agricultural Bank of China Ltd
XBER:EK7
|
CN |
|
R
|
Ross Stores Inc
XMUN:RSO
|
US |
|
UPM-Kymmene Oyj
OTC:UPMMY
|
FI |
|
V
|
Vertex Pharmaceuticals Inc
XETRA:VX1
|
US |
Wall St Price Targets
NZM2 Price Targets Summary
Novozymes A/S
According to Wall Street analysts, the average 1-year price target for NZM2 is 63.05 EUR with a low forecast of 51.04 EUR and a high forecast of 77.08 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NZM2's stock price target?
Price Target
63.05
EUR
According to Wall Street analysts, the average 1-year price target for NZM2 is 63.05 EUR with a low forecast of 51.04 EUR and a high forecast of 77.08 EUR.
What is the Revenue forecast for Novozymes A/S?
Projected CAGR
-55%
Over the last 7 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 2 years is -55%.
What is the Net Income forecast for Novozymes A/S?
Projected CAGR
-56%
Over the last 7 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 2 years is -56%.
